ReviewACS sensors2025
Optical Contact Lenses Biosensors.
Review in ACS sensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Smart wearable biosensors: a transformative synergy between diagnosis and treatment of disease.RSC advances · 2026Review
- Hydrogel-Based Ocular Drug Delivery Systems: A Bibliometric and Visualization Analysis of Research Trends and Hotspots (1991-2025).Pharmaceutics · 2026Article
- Seamless human electronics interfacing through advanced skin attachable and implantable sensor technologies.Discover nano · 2026Review
- Myopia management functional lenses (MMFL): a bibliometric analysis of multidisciplinary perspective and trend insights in the context of vision health.International ophthalmology · 2026Review
- Optical Biosensors-Principles of Operation and Applications.Micromachines · 2026Review
- Hydrogel-Based Monitoring in Perioperative Anesthesia: A Conceptual Review and Translational Perspective.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tear fluid contains a diverse array of biomarkers reflective of both ocular and systemic health, making it a valuable medium for noninvasive diagnostics. Contact lens biosensors, integrated with optical sensing technologies, provide a promising platform for real-time, continuous monitoring of tear fluid composition. This review focuses on recent advances in the development of contact lens biosensors for optical detection of tear-based biomarkers. Key components include biocompatible lens materials, such as hydrogels and silicone hydrogels, that maintain oxygen permeability and optical clarity, along with fabrication methods such as inkjet printing, micropatterning, and three-dimensional (3D) microfabrication for precise sensor integration. Optical sensing mechanisms, including fluorescence, photonic crystal resonance, and surface plasmon resonance, have demonstrated high sensitivity in detecting glucose, lactate, electrolytes, cortisol, and inflammatory markers at clinically relevant concentrations. Such sensors have shown potential in diagnosing and monitoring diseases including diabetes, dry eye syndrome, stress-related disorders, and neurodegenerative conditions. Despite these advances, challenges remain in minimizing background interference, enabling long-term wear, and achieving multiplexed detection. Future research should prioritize robust biorecognition chemistries, wireless optical readouts, and scalable manufacturing strategies to support clinical translation. Contact lens biosensors are poised to become a key platform in next-generation, personalized healthcare through noninvasive tear fluid analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.